Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by G1945Von Dec 21, 2022 12:27pm
138 Views
Post# 35184909

RE:RE:RE:RE:RE:1.2 billion fully diluted shares but $50 billion...

RE:RE:RE:RE:RE:1.2 billion fully diluted shares but $50 billion...KBC both companies are being hit hard because of the potential merger and its unknowns. Both companies are on their knees because of the predicament they got themselves into over time.

If it takes the merger for both companies to survive then so be it. We all need to decide for ourselves what we do going forward. We are stuck between a rock and a hard place. We're caught in a damned-if-you-do and damned-if-you-don't scenario. Selling shares at 5 cents at this point before the merger is set in stone, makes no sense, especially if BTI shares are held in a tax-free account where losses can't be written off. If not the most logical move would be to sell now, bank the tax loss and wait it out to see what the merger looks like and buy into the merger if one so chooses when better information hopefully will be made available then.

We all need to be practical about this convoluted deal. 


JMO
G1945V
<< Previous
Bullboard Posts
Next >>